For instance, lower levels of irisin have been detected in patients with coronary artery disease, type 2 diabetes mellitus and chronic renal disease [17,18,19], whereas circulating irisin was shown to be positively associated with insulin resistance and metabolic syndrome [20,21,22]. This evidence concerns the gene FNDC5 and metabolic syndrome.